iota medtech
iota medtech & leading healthcare institutions are working together to co-develop & deploy AI products that improve population health & early diagnosis. Starting from 2019, iota medtech & SingHealth signed an MOU to collaborate on Artificial Intelligence and in 2024 a collaboration with Tan Tock Seng Hospital started as well. These partnerships have successfully created a strong pipeline of AI products.
iScreen – AI to immediately triage urgent cases
Tested & validated in SingHealth & achieved industry leading accuracy for prioritisation of urgent hemorrhagic stroke & ICH patients.
PopuScreen – AI to assist radiologists to scale-up population screening
AI for cancer detection, classification & segmentation, starting with lung cancer.
PopuScreen 24/7 – Generative AI platform
For USA & Singapore healthcare providers to engage & onboard patients for population health screening programs, starting with lung cancer screening.
- Find – eligible patients in the EHR to join population health screening programs
- Increase – intake of patients into population health screening programs
- Enable – governments & payors to use AI to scale up population health programs
We envision a future where our Generative AI platform transforms healthcare for a billion people by enabling providers, governments & payers to scale up population level health screening.